---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-067973"
form_type: "8-K"
ticker: "WW"
cik: "0000105319"
company_name: "WW INTERNATIONAL, INC."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T18:44:15.527751+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# WW on track to beat Q1 fiscal 2024 guidance for Clinical subscribers

## Summary
- Company disclosed to employees it expects to exceed previously issued Q1 2024 guidance for end-of-period Clinical subscribers.
- Forward-looking statement subject to risks detailed in the annual report on Form 10-K filed February 28, 2024.
- No specific subscriber numbers or revised guidance range provided in the disclosure.

## SEC filing metadata
- accession: 0001193125-24-067973
- form_type: 8-K
- ticker: WW
- cik: 0000105319
- company_name: WW INTERNATIONAL, INC.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105319/000119312524067973/0001193125-24-067973-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105319/000119312524067973/d810567d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-067973
- JSON: https://secwatch.observer/filing/0001193125-24-067973.json
- Plain text: https://secwatch.observer/filing/0001193125-24-067973.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.